Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
| Product: | Shingrix |
| Active Ingredient: | Recombinant varicella zoster virus glycoprotein E 50mcg |
| Dosage Form: | Powder for injection |
| Dosage Form: | Suspension for injection |
| New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
| Manufacturers: | GlaxoSmithKline Biologicals SA (Wave Nord), Wavre, Belgium Patheon Italia S.p.A, Milan, Italy GlaxoSmithKline Biologicals SAS (France), Saint-Amand-Les-Eaux, France GlaxoSmithKline Vaccines SRL, Sovicille, Italy |
Dated this 17th day of February 2025.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).